Bulletin
Investor Alert

London Markets Close in:

ZIOPHARM Oncology Inc.

NAS: ZIOP

GO
/marketstate/country/us

Market open

 --Real time quotes

Oct 14, 2019, 11:11 a.m.

/zigman2/quotes/200291745/composite

$

4.31

Change

+0.07 +1.65%

Volume

Volume 202,910

Real time quotes

/zigman2/quotes/200291745/composite

Previous close

$ 4.24

$ 4.31

Change

+0.07 +1.65%

Day low

Day high

$4.20

$4.32

Open

52 week low

52 week high

$1.56

$7.25

Open

Insider Actions for ZIOPHARM Oncology Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
05/07/2019 James Anthony Cannon
Director
15,000   Derivative/Non-derivative trans. at $0.7 per share. 10,500
01/06/2019 Laurence James Neil Cooper
Chief Executive Officer; Director
165,178   Derivative/Non-derivative trans. at $2.24 per share. 369,998
01/06/2019 Laurence James Neil Cooper
Chief Executive Officer; Director
446,428   Award at $0 per share. 0
01/06/2019 Laurence James Neil Cooper
Chief Executive Officer; Director
337,266   Award at $0 per share. 0
01/06/2019 David M. Mauney
President
159,010   Award at $0 per share. 0
01/06/2019 Robert Hadfield
General Counsel and Secretary
117,572   Award at $0 per share. 0
01/06/2019 Kevin G. Lafond
SVP, Treasurer & CAO
37,122   Award at $0 per share. 0
12/31/2018 Laurence James Neil Cooper
Chief Executive Officer; Director
16,156   Derivative/Non-derivative trans. at $1.87 per share. 30,211
12/31/2018 Kevin G. Lafond
SVP, Treasurer & CAO
9,334   Derivative/Non-derivative trans. at $1.87 per share. 17,454
12/31/2018 Elan Z. Ezickson
Director
80,214   Award at $0 per share. 0
12/31/2018 Douglas W. Pagán
Director
40,107   Award at $0 per share. 0
12/30/2018 Laurence James Neil Cooper
Chief Executive Officer; Director
26,178   Derivative/Non-derivative trans. at $1.66 per share. 43,455
12/30/2018 Kevin G. Lafond
SVP, Treasurer & CAO
13,100   Derivative/Non-derivative trans. at $1.66 per share. 21,746
12/29/2018 Laurence James Neil Cooper
Chief Executive Officer; Director
42,920   Derivative/Non-derivative trans. at $1.66 per share. 71,247
12/29/2018 James Anthony Cannon
Director
4,315   Derivative/Non-derivative trans. at $1.66 per share. 7,162
12/29/2018 Kevin G. Lafond
SVP, Treasurer & CAO
17,667   Derivative/Non-derivative trans. at $1.66 per share. 29,327
05/05/2018 Laurence James Neil Cooper
Chief Executive Officer; Director
123,333   Derivative/Non-derivative trans. at $4.41 per share. 543,898
12/31/2017 Laurence James Neil Cooper
Chief Executive Officer; Director
16,157   Derivative/Non-derivative trans. at $4.14 per share. 66,889
12/31/2017 Caesar J. Belbel
COO, CLO, and Secretary
21,667   Derivative/Non-derivative trans. at $4.14 per share. 89,701
12/31/2017 Francois Lebel
Executive Vice President R&D
21,667   Derivative/Non-derivative trans. at $4.14 per share. 89,701
12/31/2017 Kevin G. Lafond
SVP, Treasurer & CAO
9,333   Derivative/Non-derivative trans. at $4.14 per share. 38,638
12/30/2017 Laurence James Neil Cooper
Chief Executive Officer; Director
26,178   Derivative/Non-derivative trans. at $4.14 per share. 108,376
12/30/2017 James Anthony Cannon
Director
4,301   Derivative/Non-derivative trans. at $4.14 per share. 17,806
12/30/2017 Michael Weiser
Director
6,021   Derivative/Non-derivative trans. at $4.14 per share. 24,926
12/30/2017 Caesar J. Belbel
COO, CLO, and Secretary
31,450   Derivative/Non-derivative trans. at $4.14 per share. 130,203
12/30/2017 Francois Lebel
Executive Vice President R&D
31,450   Derivative/Non-derivative trans. at $4.14 per share. 130,203
12/30/2017 Wyche Fowler
Director
6,882   Derivative/Non-derivative trans. at $4.14 per share. 28,491
12/30/2017 Kevin G. Lafond
SVP, Treasurer & CAO
13,100   Derivative/Non-derivative trans. at $4.14 per share. 54,234
12/30/2017 Murray F. Brennan
Director
6,813   Derivative/Non-derivative trans. at $4.14 per share. 28,205
12/29/2017 Laurence James Neil Cooper
Chief Executive Officer; Director
348,000   Award at $0 per share. 0
12/29/2017 James Anthony Cannon
Director
17,258   Award at $0 per share. 0
12/29/2017 Michael Weiser
Director
17,258   Award at $0 per share. 0
12/29/2017 Caesar J. Belbel
COO, CLO, and Secretary
87,000   Award at $0 per share. 0
12/29/2017 Francois Lebel
Executive Vice President R&D
116,000   Award at $0 per share. 0
12/29/2017 Wyche Fowler
Director
17,258   Award at $0 per share. 0
12/29/2017 Kevin G. Lafond
SVP, Treasurer & CAO
53,000   Award at $0 per share. 0
12/29/2017 Murray F. Brennan
Director
17,258   Award at $0 per share. 0
12/12/2017 James Anthony Cannon
Director
13,094   Derivative/Non-derivative trans. at $4.17 per share. 54,601
12/12/2017 James Anthony Cannon
Director
20,000   Derivative/Non-derivative trans. at $2.73 per share. 54,600

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
0 Purchases
0 Sales
0
0
Last 6 months
1 Purchases
0 Sales
15,000
0
Last 12 months
8 Purchases
8 Sales
1,232,719
294,848

Officers and Executives

Dr. Laurence James Neil Cooper
Chief Executive Officer & Director
Dr. David M. Mauney
President
Mr. Satyavrat Shukla
Chief Financial Officer & Executive Vice President
Ms. Lynn M. Ferrucci
SVP-IT, Human Resources & Administration
Dr. Eleanor M. de Groot
General Manager-Cell Therapy & Executive VP
Mr. Robert Hadfield
Secretary, Chief Compliance Officer & Executive VP
Ms. Heidi M. Hagen
Director
Mr. Kevin G. Lafond
Treasurer, Chief Accounting Officer & SVP-Finance
Mr. Christopher Taylor
Vice President-Corporate Communications
Mr. Scott L. Tarriff
Independent Non-Executive Chairman
Mr. Elan Z. Ezickson
Independent Director
Mr. Douglas W. Pagán
Independent Director
Dr. Scott N. Braunstein
Independent Director
Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.